Diego Muñoz-Torrero Selected Research

Cholinergic Agents (Cholinergics)

2/2024	Acetylcholinesterase: A Versatile Template to Coin Potent Modulators of Multiple Therapeutic Targets.
8/2015	Novel Levetiracetam Derivatives That Are Effective against the Alzheimer-like Phenotype in Mice: Synthesis, in Vitro, ex Vivo, and in Vivo Efficacy Studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diego Muñoz-Torrero Research Topics

Disease

18	Alzheimer Disease (Alzheimer's Disease) 02/2024 - 01/2008
5	Neuroinflammatory Diseases 02/2024 - 08/2015
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 04/2015 - 01/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2013 - 04/2003
1	Malaria 02/2024
1	Cognitive Dysfunction 07/2022
1	Amnesia (Dissociative Amnesia) 04/2022
1	Dementia (Dementias) 09/2018
1	Inflammation (Inflammations) 09/2018
1	Myasthenia Gravis 03/2018
1	Trypanosomiasis 01/2018
1	Encephalitis (Encephalitis, Rasmussen) 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2016
1	Seizures (Absence Seizure) 08/2015
1	Amyloid Plaque 03/2015
1	Dehydration (Water Stress) 04/2006
1	Gliosis 04/2003

Drug/Important Bio-Agent (IBA)

8	Amyloid (Amyloid Fibrils)IBA 04/2022 - 01/2013
7	Peptides (Polypeptides)IBA 01/2023 - 09/2010
7	AcetylcholinesteraseIBA 07/2022 - 01/2008
3	Proteins (Proteins, Gene)FDA Link 02/2024 - 09/2018
3	Epoxide HydrolasesIBA 02/2024 - 01/2022
3	rheinIBA 03/2023 - 03/2014
2	Cholinergic Agents (Cholinergics)IBA 02/2024 - 08/2015
2	EnzymesIBA 02/2024 - 01/2022
2	Trace Elements (Biometals)IBA 04/2022 - 12/2016
2	ButyrylcholinesteraseIBA 04/2022 - 03/2018
2	6-chlorotacrineIBA 01/2022 - 03/2018
2	huprine YIBA 03/2018 - 04/2003
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 03/2018 - 01/2017
2	Tacrine (Cognex)FDA Link 03/2018 - 01/2012
2	Levetiracetam (Keppra)FDA LinkGeneric 01/2017 - 08/2015
1	Therapeutic UsesIBA 12/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 07/2022
1	Scopolamine (Hyoscine)FDA Link 04/2022
1	Glycogen Synthase (Synthase I)IBA 04/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2022
1	Anti-Anxiety Agents (Anxiolytics)IBA 09/2018
1	TriazolesIBA 03/2018
1	NitrogenIBA 03/2018
1	PolyphenolsIBA 03/2018
1	quinolineIBA 03/2018
1	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 03/2018
1	Antiparasitic Agents (Antiparasitics)IBA 01/2018
1	Cyanides (Isocyanides)IBA 01/2018
1	SaltsIBA 01/2018
1	Kainic Acid (Kainate)IBA 01/2018
1	huprine XIBA 01/2018
1	Donepezil (Aricept)FDA LinkGeneric 01/2017
1	Serotonin (5 Hydroxytryptamine)IBA 12/2016
1	Monoamine Oxidase (MAO)IBA 12/2016
1	MelatoninIBA 12/2016
1	Cholinesterases (Cholinesterase)IBA 12/2016
1	sigma Receptors (sigma Receptor)IBA 12/2016
1	CateninsIBA 12/2016
1	Nicotinamide PhosphoribosyltransferaseIBA 12/2016
1	Prion ProteinsIBA 04/2015
1	shogaolIBA 10/2014
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2013
1	Amyloid beta-PeptidesIBA 09/2010
1	3-hydroxybutanal (aldol)IBA 04/2006
1	PK 11195 (PK11195)IBA 04/2003

Therapy/Procedure

2	Oral Administration 01/2022 - 03/2015